Monthly Archives: November 2008
An Inevitable Evolution
It is all about the pull and less about the push when it comes to delivering an effective and valuable message to physicians without comprising compliance. And the panelists and speakers attending the Center for Business Intelligence’s Premier Opinion Leader Management Systems conference in King of Prussia, PA, couldn’t agree more.
Over the next five years, [...]
Posted in Marketing, People Tagged Abbott, Cegedim Dendrite, Gartner, key opinion leader, UCB Pharma Leave a comment
Daschle to Spearhead Healthcare Reform
President-elect Barack Obama is moving quickly in selecting former Senate majority leader Tom Daschle as secretary of Health and Human Services. Daschle has been a close advisor to Obama, and now is slated to be the administration’s point person on moving health reform legislation through Congress. Reform advocates consider the selection a sign that the [...]
Amid Big Pharma Woes, Shire in “Best Shape Everâ€
Angus Russell, Shire’s longtime CFO—now CEO—likens the failing US automobile industry to pharma. “All the problems with the automobile industry were a long time coming,†he says. “It’s just that the SUVs and the relatively cheap price of gas created a bubble, just like a booming economy and blockbusters.â€
But now that the bubble has burst, [...]
Posted in Deals, Emerging Markets, R&D, Strategy Tagged Angus Russell, Orphan Drugs, Shire 1 Comment
Wyeth v. Levine: Inside the Preemption Case
Last week, the Supreme Court heard arguments in the long-awaited preemption case, Wyeth v. Levine.
For the first time, the highest court in the land is weighing in on whether federal approval of a drug preempts tort claims against a drugmaker, such as an injured consumer might bring in a state court. A decision for [...]
Posted in Legal, Regulatory Tagged Congress, FDA, liability, Preemption, Supreme Court, Waxman, Wyeth Leave a comment

The KOL Database Kingdom